You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leptomeningeal Metastasis

Showing 51 - 75 of 1,827
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Leptomeningeal Metastases Trial in France (Liposomal Cytarabine)

Completed
  • Breast Cancer
  • Leptomeningeal Metastases
  • Liposomal Cytarabine
  • Amiens, France
  • +9 more
Jun 11, 2019

Study of Screening Brain MRIs in Stage IV Breast Cancer

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Magnetic Resonance Imaging
  • Tampa, Florida
    Moffitt Cancer Center
Sep 30, 2022

Breast Cancer, Brain Metastases Trial (Neratinib)

Withdrawn
  • Breast Cancer
  • Brain Metastases
  • (no location specified)
Feb 28, 2022

Brain Metastases, Brain Lesion Trial in Tampa (Hypofractionated Stereotactic Radiosurgery)

Recruiting
  • Brain Metastases
  • Brain Lesion
  • Hypofractionated Stereotactic Radiosurgery
  • Tampa, Florida
    Moffitt Cancer Center
Feb 24, 2022

Breast Cancer Trial (Consultation, Cerebral and medullary MRI, lumbar puncture, CSF sampling, biological test)

Not yet recruiting
  • Breast Cancer
  • Consultation
  • +2 more
  • (no location specified)
Nov 28, 2022

Prostate Cancer Trial run by the National Cancer Institute (NCI) (PROSTVAC-F/TRICOM, PROSTVAC-V/TRICOM, Enzalutamide (Xtandi))

Active, not recruiting
  • Prostate Cancer
  • PROSTVAC-F/TRICOM
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Brain Metastases Trial in Toronto, Berlin (Stereotactic Radiosurgery)

Recruiting
  • Brain Metastases
  • Stereotactic Radiosurgery
  • Toronto, Ontario, Canada
  • +1 more
Apr 14, 2022

Brain Metastases Trial in Little Rock (SRS/SRT)

Recruiting
  • Brain Metastases
  • SRS/SRT
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Jun 8, 2022

Clinical, Radiological, Histologic and Molecular Features

Recruiting
  • Meningeal Melanocytoma
  • +3 more
    • Nancy, France
      Nancy University Hospital Center
    Jul 31, 2023

    Brain Metastases Trial in Milwaukee (Stereotactic Radiosurgery)

    Recruiting
    • Brain Metastases
    • Stereotactic Radiosurgery
    • Milwaukee, Wisconsin
      Froedtert Hospital & Medical College of Wisconsin
    Mar 2, 2022

    Brain Metastases, Adult Trial in Heidelberg (post-operative stereotactic radiosurgery (SRS), Whole brain radiotherapy (WBRT))

    Completed
    • Brain Metastases, Adult
    • post-operative stereotactic radiosurgery (SRS)
    • Whole brain radiotherapy (WBRT)
    • Heidelberg, Germany
      Department of Radiotherapy, University of Heidelberg
    Nov 2, 2022

    Brain Oligometastases Receiving Hypofractionated SRT

    Recruiting
    • Brain Metastases, Adult
    • Hypofractionated Stereotactic Radiotherapy
    • Taoyuan, Taiwan
    • +1 more
    Mar 8, 2022

    Brain Metastases, Adult Trial (Hypofractionated Radiosurgery (HSRS), Brain metastases surgical resection)

    Not yet recruiting
    • Brain Metastases, Adult
    • Hypofractionated Radiosurgery (HSRS)
    • Brain metastases surgical resection
    • (no location specified)
    Oct 4, 2022

    Brain Metastases, Nsclc Trial in Heidelberg (SRS, Whole Brain Radiotherapy)

    Recruiting
    • Brain Metastases
    • Nsclc
    • SRS
    • Whole Brain Radiotherapy
    • Heidelberg, Germany
      University Hospital of Heidelberg, Radiation Oncology
    May 13, 2022

    Multiple Sclerosis Trial in Moskva, Saint-Petersburg (Ocrelizumab)

    Recruiting
    • Multiple Sclerosis
    • Moskva, Moskovskaja Oblast, Russian Federation
    • +1 more
    Aug 2, 2022

    Meningeal Tumors, Leptomeningeal Disease Trial in Tübingen (No intervention)

    Not yet recruiting
    • Meningeal Neoplasms
    • Leptomeningeal Disease
    • No intervention
    • Tübingen, Germany
      University Hospital Tübingen, Neurooncology
    Nov 16, 2023

    Cerebral Metastases, Surgery Trial in Düsseldorf (Cavity boost radiation)

    Recruiting
    • Cerebral Metastases
    • Surgery
    • Cavity boost radiation
    • Düsseldorf, NRW, Germany
      Heinrich-Heine-University
    Mar 21, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Leptomeninges Trial in

    Not yet recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +2 more
    • Digital Photography
    • +3 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Feb 28, 2023

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

    Recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 9, 2022

    Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)

    Recruiting
    • Leptomeningeal Disease
    • +2 more
    • Dendritic Cell Vaccine
    • Tampa, Florida
      Moffitt Cancer Center
    Apr 11, 2023

    Brain Metastases Trial in Calgary, Edmonton (Brain Surgery, Stereotactic Radiosurgery)

    Recruiting
    • Brain Metastases
    • Brain Surgery
    • Stereotactic Radiosurgery
    • Calgary, Alberta, Canada
    • +1 more
    Sep 28, 2021

    Leptomeningeal Disease Trial in Germany (Nivolumab [Opdivo])

    Recruiting
    • Leptomeningeal Disease
    • Nivolumab [Opdivo]
    • Freiburg, Germany
    • +6 more
    Nov 2, 2022

    Clinical Stage IIA Cutaneous Melanoma AJCC v8 Trial in Portland (drug, procedure, other)

    Not yet recruiting
    • Clinical Stage IIA Cutaneous Melanoma AJCC v8
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Nov 27, 2023

    Multiple Brain Metastases Trial in United States (BMX-001, Whole Brain Radiation Therapy)

    Recruiting
    • Multiple Brain Metastases
    • Lexington, Kentucky
    • +3 more
    Jul 11, 2022

    Nasopharyngeal Tumors Trial (The combination treatment of anlotinib, penpulimab and capecitabine.)

    Not yet recruiting
    • Nasopharyngeal Neoplasms
    • The combination treatment of anlotinib, penpulimab and capecitabine.
    • (no location specified)
    Apr 10, 2023